Caxton Associates (UK)’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$212K Buy
+15,621
New +$187K ﹤0.01% 701
2026
Q1
Sell
-11,128
Closed -$79.8K 942
2025
Q4
$79.8K Buy
+11,128
New +$87.9K ﹤0.01% 751

Other funds holding OGN

Caxton Associates (UK)'s OGN Position: Q2 2026 in Review

Caxton Associates (UK) opened a new position in Organon & Co (OGN) in Q2 2026: 15,621 shares worth $212K. The stake represents ﹤0.01% of the portfolio and ranks #701 among its holdings. This is a return to the name: Caxton Associates (UK) previously reported a position in OGN as recently as Q4 2025.

Caxton Associates (UK) first reported a position in OGN in Q4 2025 and has held it in 2 quarters since. 631 funds tracked by Wall St. Rank hold OGN as of Q2 2026.

  • Caxton Associates (UK) held 15,621 shares of Organon & Co worth $212K as of Q2 2026.
  • Organon & Co was a new Caxton Associates (UK) position in Q2 2026.
  • Organon & Co made up ﹤0.01% of Caxton Associates (UK)'s portfolio in Q2 2026, its #701 holding.
  • Caxton Associates (UK) first reported a position in Organon & Co in Q4 2025 and has held it in 2 quarters since.
  • 631 funds tracked by Wall St. Rank held Organon & Co as of Q2 2026.

Based on Caxton Associates (UK)'s 13F filing for Q2 2026, filed 14 Aug 2026.